Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes
Open Access
- 12 March 2004
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 4 (1) , 1-12
- https://doi.org/10.1186/1471-2407-4-9
Abstract
Subtle functional deficiencies in highly conserved DNA repair or growth regulatory processes resulting from polymorphic variation may increase genetic susceptibility to breast cancer. Polymorphisms in DNA repair genes can impact protein function leading to genomic instability facilitated by growth stimulation and increased cancer risk. Thus, 19 single nucleotide polymorphisms (SNPs) in eight genes involved in base excision repair (XRCC1, APEX, POLD1), BRCA1 protein interaction (BRIP1, ZNF350, BRCA2), and growth regulation (TGFß1, IGFBP3) were evaluated. Genomic DNA samples were used in Taqman 5'-nuclease assays for most SNPs. Breast cancer risk to ages 50 and 70 were estimated using the kin-cohort method in which genotypes of relatives are inferred based on the known genotype of the index subject and Mendelian inheritance patterns. Family cancer history data was collected from a series of genotyped breast cancer cases (N = 748) identified within a cohort of female US radiologic technologists. Among 2,430 female first-degree relatives of cases, 190 breast cancers were reported. Genotypes associated with increased risk were: XRCC1 R194W (WW and RW vs. RR, cumulative risk up to age 70, risk ratio (RR) = 2.3; 95% CI 1.3–3.8); XRCC1 R399Q (QQ vs. RR, cumulative risk up to age 70, RR = 1.9; 1.1–3.9); and BRIP1 (or BACH1) P919S (SS vs. PP, cumulative risk up to age 50, RR = 6.9; 1.6–29.3). The risk for those heterozygous for BRCA2 N372H and APEX D148E were significantly lower than risks for homozygotes of either allele, and these were the only two results that remained significant after adjusting for multiple comparisons. No associations with breast cancer were observed for: APEX Q51H; XRCC1 R280H; IGFPB3 -202A>C; TGFß1 L10P, P25R, and T263I; BRCA2 N289H and T1915M; BRIP1 -64A>C; and ZNF350 (or ZBRK1) 1845C>T, L66P, R501S, and S472P. Some variants in genes within the base-excision repair pathway (XRCC1) and BRCA1 interacting proteins (BRIP1) may play a role as low penetrance breast cancer risk alleles. Previous association studies of breast cancer and BRCA2 N372H and functional observations for APEX D148E ran counter to our findings of decreased risks. Due to the many comparisons, cautious interpretation and replication of these relationships are warranted.Keywords
This publication has 42 references indexed in Scilit:
- The HER2 I655V Polymorphism and Breast Cancer Risk in AshkenazimEpidemiology, 2003
- Mutational analysis of theBRCA1-interacting genesZNF350/ZBRK1andBRIP1/BACH1amongBRCA1andBRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individualsHuman Mutation, 2003
- Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2003
- Kin-cohort evaluation of relative risks of genetic variantsGenetic Epidemiology, 2003
- Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityJournal of Medical Genetics, 2002
- Polygenic susceptibility to breast cancer and implications for preventionNature Genetics, 2002
- Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based studyGenetic Epidemiology, 2001
- Heritability of Cellular Radiosensitivity: A Marker of Low-Penetrance Predisposition Genes in Breast Cancer?American Journal of Human Genetics, 1999
- Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation?Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1998
- Polymorphisms of the Transforming Growth Factor-β1 Gene in Relation to Myocardial Infarction and Blood PressureHypertension, 1996